We report 4 patients who developed hyperphosphatemia while receiving liposomal amphotericin B to treat an invasive fungal infection. Resolution of the hyperphosphatemia occurred after transition to amphotericin B lipid complex. This phenomenon may occur more commonly in patients with mild to moderate renal insufficiency.
- Amphotericin B
- Invasive fungal infection
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Microbiology (medical)